Status:
COMPLETED
Study of Improving Insulin Sensitivity by Electroacupuncture Therapy
Lead Sponsor:
China Medical University Hospital
Collaborating Sponsors:
China Medical University, China
Conditions:
Diabetes Mellitus, Type 2
Insulin Resistance
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
The aim of this study is to find out whether the hypoglycemic and improving insulin resistance effect will appear or not, when EA applying on specific acupoints of NIDDM patients.
Detailed Description
Some previous animal model studies reveal that electroacupuncture (EA) applying on specific acupoints, such as Zhongwan and Zusanli acupoint, can reduce plasma glucose levels and encourage insulin sec...
Eligibility Criteria
Inclusion
- newly diagnosed NIDDM patient within 5 years
- age between 30 to 65 years old
- controlled BP below 140/90 mmHg
- oral hypoglycemic agent (OHA) therapy with Gliclazide twice per day.
Exclusion
- disorders of hemostasis
- patient had received insulin therapy
- severe disease such as CVA, CAD within 6 months
- Arrhythmia history and on pacemaker.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00379379
Start Date
January 1 2005
End Date
December 1 2005
Last Update
September 21 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Graduate Insititude of Integration Chinese And Western Medicine, China Medical University
Taichung, Taiwan, 40402